Patent · US Active

Lipid formulation

US8802644B2 · kind B2 · utility

110Cited by

0References

35Claims

0Family size

Assignee

Tekmira Pharmaceuticals Corporation · CA

Inventors

Jianxin Chen · Cambridge, US
Steven M. Ansell · Vancouver, CA
Akin Akinc · Cambridge, US
Joseph R. Dorkin · Somerville, US
Xiaojun Qin · Cambridge, US
William Cantley · Cambridge, US
Muthiah Manoharan · Carlsbad, US
Kallanthottathil G. Rajeev · Wayland, US
Jayaprakash K. Narayanannair · Cambridge, US
Muthusamy Jayaraman · Cambridge, US

Key dates

Filing date	Jan 25, 2012
Grant date	Aug 12, 2014
Priority date	—
Expiry date	Jun 6, 2032

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention features a cationic lipid of formula I, Also disclosed are targeting lipids, and specific lipid formulations comprising such targeting lipids.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.